International safety notice
MyCare Insite Clozapine Test. Referencia: CLZ-MCI
Spain / AEMPS · ESP · Feb 28, 2020
Key facts
| Title | MyCare Insite Clozapine Test. Referencia: CLZ-MCI |
|---|---|
| Regulator | Spain / AEMPS |
| Country | ESP |
| Brand | MyCare Insite Clozapine Test. Referencia: CLZ-MCI |
| Manufacturer | SALADAX BIOMEDICAL, INC., EEUU |
| Models | 2020-115, 19-078, 28022, SBI046.F1, 18015, 91.822.52.89, AN-028, 58101, 28232, LOTE19-078, 419-6731 |
| Event type | Safety Notice |
| Date | Feb 28, 2020 |
At a glance
- No Recall
- Yes Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1